Healthcare IT News November 27, 2024
The announcement comes about four months after Musk relayed his vision for patients with an Optimus robotic arm or leg to have the ability to control their limbs with the N1 implant.
Elon Musk’s brain-computer interface implant startup Neuralink announced on X that it received approval to launch a new feasibility study, CONVOY, which will test the use of its wireless brain-computer interface (BCI), or N1 implant, to control an investigational assistive robotic arm.
“This is an important first step towards restoring not only digital freedom, but also physical freedom. More info to come, but the CONVOY Study will enable cross-enrolling participants from the ongoing PRIME Study,” Neuralink said in a post.
Neuralink’s PRIME study (short for Precise Robotically...
Today's Sponsors
Today's Sponsor